The Partnership for Safe Medicines is pleased to announce the keynote speaker for Interchange 2014 on September 18, in Washington DC: Howard Sklamberg, Deputy Commissioner for the FDA’s Global Regulatory Operations and Policy. Deputy Commissioner Sklamberg directs the Office of Regulatory Affairs and the Office of International Programs. He oversees the FDA’s efforts to supervise…
In his op-ed featured in The Hill on March 1, 2014, LaGanga anticipated that the recent hearing Counterfeit Drugs, Fighting Illegal Supply Chains will spark new efforts by the government to educate patients and take stronger action to stop this growing health threat. He encouraged policymakers to better understand the real nature of the threats posed…
Photo Credit: Pfizer Corporation. Decision by European Parliament gives front-line customs agents the power to seize suspected counterfeit medications that cross their border even if they are in transit to a different country. The European Parliament passed a draft law making it easier for customs authorities to intercept counterfeit medications that pass in transit between…
Washington, D.C. (February 27, 2014) – Marv Shepherd, President of the Partnership for Safe Medicines (PSM), released the following statement on today’s hearing on counterfeit medicines held by the House Energy and Commerce Committee’s Subcommittee on Oversight and Investigations. The hearing, titled “Counterfeit Drugs: Fighting Illegal Supply Chains” brought to light some disturbing trends that must…
In Online Availability And Safety Of Drugs In Shortage: A Descriptive Study Of Internet Vendor Characteristics, Dr. Tim Mackey and Dr. Bryan Liang examined how Internet pharmaceutical vendors take advantage of known drug shortages to market unapproved and unsafe versions of these medications directly to consumers. Find out why drug shortages play into the hands…
Black market medicine distributors have impacted patient health in many areas. We examined two different therapeutic areas of non-FDA approved medication infiltrating the secure U.S. drug supply chain. Learn more about the prescription drug black market and what policy makers, medical professionals, patients and consumers can do to protect the secure U.S. drug supply chain.…
Take a moment to peruse “Are Tier One Countries Safe to Import Medicine From?” and teach yourself about the true dangers inherent in medicine importation. The Partnership for Safe Medicines answers the question of drug importation safety with a resource designed to make clear the real costs you incur when you purchase non-FDA approved medications from…
The Partnership has released a new version of this publication. Please consult the 2017 edition here. Download and read Counterfeit Drugs: A dangerous threat to American patients. This resource developed by The Partnership for Safe Medicines explains the counterfeit medicines issues as they impact the U.S. Explaining the breadth of the problem, it then details the…
An illicit drug lab operating in Longueuil, Canada was outfitted to produce thousands of pills. Alleged lab owner, Alexandre Beaudry is scheduled to appear in court on charges relating to these operations on February 20, 2014. The Royal Canadian Mounted Police (RCMP) reported that their Clandestine Laboratory Enforcement Team (CLET) have dismantled a counterfeit drug…
When CBS Dallas reported on prescription fulfillment errors in Texas pharmacies, they reached out to The Partnership for Safe Medicine’s Board President, Dr. Marvin D. Shepherd to discuss the prevention of dispensing errors. Dr. Shepherd is Director of the Center for Pharmacoeconomic Studies and Chairman of the Pharmacy Administration Division at the University of Texas…